Ascendis Pharma A (ASND) FCF Margin (2014 - 2026)
Ascendis Pharma A's FCF Margin was 83.02% in the quarter ended Jun 30, 2026, up 87.67 percentage points from -4.64% a year earlier and up 86.15 percentage points from the prior quarter.
Ascendis Pharma A (ASND) FCF Margin (2014 - 2026) Analysis & Trends
On a trailing twelve-month basis, Ascendis Pharma A's FCF Margin was 16.15% through Jun 30, 2026, up 49.59 percentage points year-over-year; for the year ended Dec 31, 2025, it came in at -17.47%, up 57.99 percentage points from the prior year.
- FCF Margin has now increased for four consecutive years, with a five-year change of +3602.38 percentage points (years ended Dec 2020 to Dec 2025).
- In earlier years, FCF Margin was -75.46% in the year ended Dec 31, 2024 (+99.77 pp), -175.23% in the year ended Dec 31, 2023 (+812.06 pp), -987.29% in the year ended Dec 31, 2022 (+4382.33 pp) and -5369.62% in the year ended Dec 31, 2021 (-1749.77 pp).
- The figure for the quarter ended Jun 30, 2026 marks the highest quarterly FCF Margin in data going back to the quarter ended Mar 31, 2014.
- Compared with a year earlier, FCF Margin has increased for six straight quarters, with an average year-over-year change of +73.19 percentage points over the last eight quarters.
- The best year-over-year quarter for FCF Margin over five years was the quarter ended Jun 30, 2022 (a gain of 8962.74 percentage points); the worst was the quarter ended Sep 30, 2021 (a drop of 5826.05 percentage points).
- Per Business Quant data, ASND's FCF Margin in the three quarters before the quarter ended Jun 30, 2026 was -3.13% (quarter ended Mar 31, 2026), -42.94% (quarter ended Dec 31, 2025) and 1.01% (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 30.39% |
| 10 | Ascendis Pharma A | 14.12 Bn | 10.37 Bn | 362.22 Mn | 83.02% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 83.02% |
| Mar 31, 2026 | -3.13% |
| Dec 31, 2025 | -42.94% |
| Sep 30, 2025 | 1.01% |
| Jun 30, 2025 | -4.64% |
| Mar 31, 2025 | -14.18% |
| Dec 31, 2024 | -50.70% |
| Sep 30, 2024 | -96.25% |
| Jun 30, 2024 | -169.36% |
| Mar 31, 2024 | -105.72% |
| Dec 31, 2023 | -14.86% |
| Sep 30, 2023 | -257.62% |
| Jun 30, 2023 | -322.17% |
| Mar 31, 2023 | -434.54% |
| Dec 31, 2022 | -707.26% |
| Sep 30, 2022 | -625.70% |
| Jun 30, 2022 | -1,958.88% |
| Mar 31, 2022 | -1,859.55% |
| Dec 31, 2021 | -165.12% |
| Sep 30, 2021 | -7,746.54% |
Ascendis Pharma A FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=ASND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "ASND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=ASND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();